Know your risk.

Individuals of Ashkenazi Jewish descent have a one-in-forty risk of inheriting a BRCA gene mutation, increasing their risk of developing hereditary breast (male or female), ovarian and prostate cancer.

Learn More

Dear Friends of Oneinforty,

Since Oneinforty was established five years ago by our visionary and impassioned founder, the late Lauren Corduck, our mission has remained the same: to raise awareness of the one-in-forty risk to those of Ashkenazi Jewish (Eastern European) descent of inheriting BRCA gene mutations, and to provide education and support to individuals and families to help them manage their cancer risk. Your participation and support for our mission has been critical to our success.

Over the past year, due to the challenges presented by the pandemic and administrative changes within the organization, it became clear to the Board of Directors that the best way to ensure the continuation of Oneinforty’ s mission and work would be to partner with an organization with a similar purpose and programs.

We have found such an organization in Sharsheret, a national nonprofit whose mission is to improve the lives of Jewish women and families living with or at increased genetic risk for breast or ovarian cancer through personalized support and save lives through educational outreach.

Under this new partnership, Oneinforty has made a significant grant to Sharsheret to develop and facilitate an educational outreach program in New England for the next five years that will focus on cancer genetics, highlighting the elevated risks for inheriting the BRCA genetic mutation and hereditary cancer among Ashkenazi Jews. Sharsheret is using the name Oneinforty in the promotion of the program and Robb Corduck, Lauren’s husband, is serving on Sharsheret’s national board to ensure the continuation of Oneinforty’s mission.

Thank you for your loyal support over the past five years, and if you wish to provide financial support to continue our mission, we invite you to do so through Sharsheret.

Please feel free to reach out with any questions about this important next step in the Oneinforty journey.

Bob Cooperstein, President
Oneinforty Board of Directors


by our roots

American Jews of eastern and central European descent (Ashkenazi) have a one in forty risk of having a mutation in their BRCA1 or BRCA2 gene that puts them at much higher risk than the general population of developing ovarian cancer, breast cancer (male or female) and prostate cancer.

What Is BRCA?


by knowledge

Both men and women are at risk of developing hereditary cancer and can pass on a BRCA 1 or 2 gene mutation. It’s important to know your family history and to speak with a genetic counselor. With knowledge of your risk, you can make informed decisions to protect you and your family’s health.

Read Stories


by resources

Oneinforty supports the community with an ambassador program and social media channels, offers educational symposia with expert oncologists and genetic counselors, physician education and emotional support through a cadre of mental health providers.


“I am Oneinforty” Stories

“It was a long journey and I didn’t come to my decision quickly. Having a mastectomy meant I could put my family history of breast cancer behind me, and I felt relief.”

Read Caitlin's Story

“A clinical breast exam does not appear on the to-do lists of many men. But it should…at least for one in every forty Ashkenazi Jews like me.”

Read Eric's Story

“While being aware of my BRCA1 positive status did not prevent me from being diagnosed it did allow me to avoid what almost certainly would have evolved into to advanced ovarian cancer.

Read Susan's Story

October 27, 2022

Knowledge is Power: Genetics and Cancer Risk within the Jewish Community

Learn More

Oneinforty was founded from personal experience.

In late 2016 at the age of forty-five, Lauren Corduck underwent genetic testing which found she had inherited the BRCA1 gene mutation from her father. Even though there was a family history of breast cancer and she was of Ashkenazi Jewish descent, Lauren had never been advised by a physician to seek genetic testing. Almost simultaneously to learning of her BRCA mutation, she was diagnosed with Stage 4 ovarian cancer. Lauren, who died in December of 2020, started Oneinforty in 2017, with the goal of helping other families avoid a similar experience.

Read more about Lauren’s journey. »

Read about Oneinforty in the news.

Boston Globe
Lauren Corduck, who founded Oneinforty to raise cancer risk awareness, dies at 49
Read the Article
Local cancer survivor raises awareness of cancer gene mutation risk
Read the Article
New York Times
Raising Awareness ofBRCA Mutations
Read the Article